Insider Selling: Akoya Biosciences, Inc. (NASDAQ:AKYA) CEO Sells 7,500 Shares of Stock

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) CEO Brian Mckelligon sold 7,500 shares of the company’s stock in a transaction dated Tuesday, December 19th. The stock was sold at an average price of $4.48, for a total value of $33,600.00. Following the completion of the transaction, the chief executive officer now owns 152,563 shares […]

Related Keywords

United States ,America ,American ,Asia Pacific ,Brian Mckelligon ,Piper Sandler ,Akoya Biosciences ,Morgan Stanley ,Charles Schwab Investment Management Inc ,Akoya Biosciences Company Profile ,American International Group Inc ,Investment Counsel Inc ,Jpmorgan Chase Co ,Nasdaq ,Akoya Biosciences Inc ,Get Free Report ,International Group ,Schwab Investment Management ,North America ,Middle East ,Akoya Biosciences Daily ,Nasdaq Akya ,Sakya ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,